Takeda Pharmaceutical
303 hedge funds and large institutions have $1.6B invested in Takeda Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 93 increasing their positions, 103 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $1.97B → $1.6B (-$368M)
29% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 41
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
303
Holding in Top 10
1
Calls
$58.8M
Puts
$28.6M
Top Buyers
| 1 | +$23.2M | |
| 2 | +$12.7M | |
| 3 | +$11M | |
| 4 |
Citigroup
New York
|
+$8.31M |
| 5 |
Barclays
London,
United Kingdom
|
+$7.83M |
Top Sellers
| 1 | -$118M | |
| 2 | -$86.3M | |
| 3 | -$54.3M | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$21.1M |
| 5 |
Renaissance Technologies
New York
|
-$19.1M |